These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7660881)

  • 21. Synthesis and biological activities of 2-functionalized purine nucleosides.
    Nair V; Bera B; Kern ER
    Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):115-27. PubMed ID: 12744599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase.
    Pitts WJ; Guo J; Dhar TG; Shen Z; Gu HH; Watterson SH; Bednarz MS; Chen BC; Barrish JC; Bassolino D; Cheney D; Fleener CA; Rouleau KA; Hollenbaugh DL; Iwanowicz EJ
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2137-40. PubMed ID: 12127522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
    Wright DG; Boosalis M; Malek K; Waraska K
    Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
    Jayaram HN; Cooney DA; Grusch M; Krupitza G
    Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
    Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
    Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
    Barnes BJ; Izydore RA; Eakin AE; Hall IH
    J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
    Shu Q; Nair V
    Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3.
    Watterson SH; Dhar TG; Ballentine SK; Shen Z; Barrish JC; Cheney D; Fleener CA; Rouleau KA; Townsend R; Hollenbaugh DL; Iwanowicz EJ
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1273-6. PubMed ID: 12657262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential mechanisms of benzamide riboside mediated cell death.
    Polgar D; Gfatter S; Uhl M; Kassie F; Leisser C; Krupitza G; Grusch M
    Curr Med Chem; 2002 Apr; 9(7):765-71. PubMed ID: 11966440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
    Franchetti P; Grifantini M
    Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
    Szekeres T; Sedlak J; Novotny L
    Curr Med Chem; 2002 Apr; 9(7):759-64. PubMed ID: 11966439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
    Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M
    J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
    Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P
    Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationally designed inhibitors of inosine monophosphate dehydrogenase.
    Zhang HZ; Rao K; Carr SF; Papp E; Straub K; Wu JC; Fried J
    J Med Chem; 1997 Jan; 40(1):4-8. PubMed ID: 9016322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
    Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient synthesis of benzamide riboside, a potential anticancer agent.
    Bonnac LF; Gao GY; Chen L; Patterson SE; Jayaram HN; Pankiewicz KW
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1249-53. PubMed ID: 18066762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
    J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cofactor-type inhibitors of inosine monophosphate dehydrogenase via modular approach: targeting the pyrophosphate binding sub-domain.
    Felczak K; Chen L; Wilson D; Williams J; Vince R; Petrelli R; Jayaram HN; Kusumanchi P; Kumar M; Pankiewicz KW
    Bioorg Med Chem; 2011 Mar; 19(5):1594-605. PubMed ID: 21324702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor.
    Chen L; Gao G; Bonnac L; Wilson DJ; Bennett EM; Jayaram HN; Pankiewicz KW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3152-5. PubMed ID: 17395461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
    Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.